Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT03131492

NCT03131492
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with ovarian cancer at stage 3 or stage 4
  • Your treatment requires surgery that includes removing part of the intestine

Who may not be able to join:

  • You have an infection that has been diagnosed at the time of your surgery
  • Your surgery is needed urgently or as an emergency procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Registry
clinicaltrials_gov
Start date
1 March 2017
Est. completion
31 December 2020

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Number of patients with anastomotic leak detected by elevation of C-reactive protein and procalcitonin levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov